Issue 4, 2025

Correction: Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors

Abstract

Correction for ‘Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors’ by Sanjay Adhikary et al., RSC Med. Chem., 2025, 16, 1105–1130, https://doi.org/10.1039/d4md00719k.

Associated articles

Article information

Article type
Correction
Submitted
20 Mar 2025
Accepted
20 Mar 2025
First published
03 Apr 2025
This article is Open Access
Creative Commons BY license

RSC Med. Chem., 2025,16, 1842-1842

Correction: Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors

S. Adhikary, S. Roy, S. Budhathoki, S. Chowdhury, A. Stillwell, A. G. Basnakian, A. Tackett, N. Avaritt, M. Milad and M. A. Alam, RSC Med. Chem., 2025, 16, 1842 DOI: 10.1039/D5MD90014J

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements